
Sebastien Foll
Journalist

Bayer edges slightly higher after cardiology progress
Bayer said on Sunday it has been granted a late-breaking presentation slot for new data from a Phase III trial of its investigational imaging agent for diagnosing cardiac amyloidosis, at the European Society of Cardiology (ESC) congress currently under way in Berlin.
August 31, 2026 at 04:24 am
Ulta Beauty beats expectations, but gross margin disappoints
US beauty products retailer Ulta Beauty last night reported quarterly results that topped expectations for its second quarter and raised its full-year outlook, but its gross margin appeared to disappoint the market.
August 28, 2026 at 11:33 am
Gap roars out of the gate, an inflection point in sight
Gap opened sharply higher Friday on the New York Stock Exchange after reporting quarterly results last night that topped expectations and raising its full-year earnings-per-share forecast, two pieces of good news that are leading analysts to think the American apparel group may be nearing an inflection point.
August 28, 2026 at 10:59 am
Analysts keep Pernod Ricard shares under pressure
Pernod Ricard shares continued to slide Friday on the Paris stock exchange, once again posting the sharpest decline in the CAC 40, after several financial intermediaries cut their price targets and forecasts a day after the world's No. 2 spirits group reported disappointing full-year results.
August 28, 2026 at 10:10 am

Philips strengthens its collaboration with Imricor in cardiac MRI
Philips said Friday it is launching with U.S.-Australian group Imricor a new interventional MRI technology for cardiac procedures, further strengthening the long-standing collaboration between the two companies.
August 28, 2026 at 04:23 am
Estee Lauder extends its turnaround, BofA targets $120
Estee Lauder is trading higher on Thursday on the New York Stock Exchange, supported by upbeat comments from Bank of America analysts who say they still see upside in the stock despite a gain of about 20% since last week's release of fourth-quarter results.
August 27, 2026 at 10:51 am
AlphaValue sticks with a Buy on EssilorLuxottica despite governance uncertainty
AlphaValue reiterated its Buy rating on EssilorLuxottica on Thursday, arguing that the stock's recent slide offers an attractive entry point despite governance tensions and the current wave of technology challenges.
August 27, 2026 at 10:20 am
Stadler Rail jumps on the stock market after a solid first half
Stadler Rail is up more than 16% on Wednesday on the Zurich stock exchange after sharply improving its first-half results, thanks to a high pace of deliveries, and reaffirming its targets for the full year.
August 26, 2026 at 05:06 am
Dick's Sporting Goods plunges after warning, dragged down by Foot Locker
Sporting goods retailer Dick's Sporting Goods is plunging more than 25% Tuesday morning on the New York Stock Exchange after posting quarterly results that missed expectations and cutting its full-year outlook, citing a market it says is becoming increasingly competitive.
August 25, 2026 at 10:49 am

Argenx keeps climbing, shrugging off Deutsche Bank's reservations
Argenx shares extended their rally on Tuesday on the Brussels exchange, confirming the positive trajectory that began last week after the company presented encouraging data in autoimmune myositis, even as Deutsche Bank analysts urged investors to take a breather after the stock's powerful surge.
August 25, 2026 at 05:29 am
Ulta Beauty stands out days ahead of its earnings
Ulta Beauty was higher Monday on the New York Stock Exchange just days ahead of the release of its quarterly results, which analysts say should point to solid performance and possibly an upward revision to its full-year guidance.
August 24, 2026 at 11:01 am

Bayer's Hyrnuo approved in Japan for HER2-mutated non-small cell lung cancer
Bayer said on Monday that Japan's Ministry of Health, Labour and Welfare has granted marketing authorization for its targeted therapy Hyrnuo to treat non-small cell lung cancer with a HER2 gene mutation.
August 24, 2026 at 05:39 am
Jefferies raises its target on Haleon, which edges slightly higher in London
Jefferies said Monday that it has raised its price target on Haleon to 410 pence from 400 pence, after the UK consumer health specialist reported better-than-expected first-half results, highlighting solid cost discipline
August 24, 2026 at 05:06 am
Richemont leads the SMI, Oddo says the stock remains attractive
Richemont is posting the biggest gain on the SMI index on the Zurich stock exchange on Monday morning, supported by positive comments from analysts at Oddo BHF, who say the luxury group's valuation remains attractive despite its recent run-up. At 10:00 a.m., the stock is up more than 1% at 187.7 Swiss francs, compared with a 0.1% dip for the SMI.
August 24, 2026 at 04:20 am
With Nvidia and Jackson Hole, markets are already back from summer break
European equities are expected to start Monday morning without a clear direction, in jittery markets ahead of a pivotal week that will be marked, among other things, by Nvidia's closely watched results and the traditional Jackson Hole gathering. Based on the first available indications, Paris' CAC 40 is seen opening up around 0.2%, but Frankfurt's DAX is expected down about 0.2%. The Euro STOXX 50 is off a little more than 0.1% in pre-open trading.
August 24, 2026 at 02:30 am
Discover our authors
Chief Editor
Journalist
Analyst
Analyst
Analyst
- Stock Market
- Our authors
- Sebastien Foll






















